Telix Pharmaceuticals to Acquire RLS (USA) to Expand North American Radiopharmacy Manufacturing and Distribution

Telix Pharmaceuticals Acquires ARTMS Inc.

March 5, 2024

Pharmaceuticals

Telix Pharmaceuticals Limited has completed the acquisition of ARTMS Inc., a Burnaby, British Columbia-based developer of cyclotron-based isotope production technology and the QUANTM Irradiation System (QIS). The deal strengthens Telix's vertical integration and supply-chain control for key diagnostic and therapeutic radioisotopes (including 89Zr, 68Ga, 99mTc and 64Cu) to support its commercial products and pipeline.

Telix Pharmaceuticals Acquires QSAM Biosciences

February 8, 2024

Biotechnology

Telix Pharmaceuticals Limited has entered into an agreement to acquire QSAM Biosciences, Inc., adding QSAM's lead radiopharmaceutical candidate 153Sm-DOTMP (Samarium-153-DOTMP) to Telix's therapeutic pipeline. The asset expands Telix's oncology focus into bone-targeting radiopharmaceuticals with potential applications in pain management of bone metastases and osteosarcoma (including pediatric indications).

Warburg Pincus and Tilia Acquire FlexXray from Levine Leichtman Capital Partners

July 26, 2021

Food & Beverage

Warburg Pincus and Tilia Holdings have acquired FlexXray, a leading provider of x-ray inspection and recovery services for the food industry, from Levine Leichtman Capital Partners. The investment is intended to support FlexXray's growth and expansion of its food-safety inspection capabilities and geographic reach; financial terms were not disclosed.

LIXTE Biotechnology Acquires Liora Technologies Europe Ltd

November 25, 2025

Medical Devices

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) has completed the acquisition of Liora Technologies Europe Ltd., a UK-based developer of the LiGHT proton therapy system. The deal brings Liora's proprietary LiGHT System and Daresbury-based operations into LIXTE as a wholly owned subsidiary to expand the company's capabilities into radiotherapy and pursue joint treatment-center revenue models.

Resource Label Group Acquires Pharmaceutic Litho and Label Company

June 15, 2023

Packaging

Resource Label Group (RLG), a portfolio company of Ares Management, has acquired Pharmaceutic Litho and Label Company (PLLC), a manufacturer of printed inserts, labels and packaging components with locations in Simi Valley, California and Winston-Salem, North Carolina. PLLC will combine with RLG's recently acquired MedLit Solutions to expand and strengthen RLG's national pharmaceutical and healthcare packaging capabilities.

Full-Life Technologies Acquires Focus‑X Therapeutics

November 28, 2022

Biotechnology

Full‑Life Technologies, a global radiotherapeutics company, agreed to acquire New Jersey‑based Focus‑X Therapeutics to expand its peptide‑focused radiopharmaceutical pipeline. Focus‑X shareholders are eligible for an upfront payment plus up to $245 million in development, regulatory and sales milestones and royalties; the deal was expected to close in Q1 2023.